Healthcare provider profile · identity verified

David E. Cox, DO

Family Practice · VANDALIA, OH · NPI 1407895543

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	509	133
Levothyroxine Sodium	Levothyroxine Sodium	383	94
Metformin Hcl	Metformin Hcl	328	91
Amlodipine Besylate	Amlodipine Besylate	291	71
Lisinopril	Lisinopril	268	71
Losartan Potassium	Losartan Potassium	210	54
Omeprazole	Omeprazole	179	46
Pantoprazole Sodium	Pantoprazole Sodium	168	42
Gabapentin	Gabapentin	157	50
Sertraline Hcl	Sertraline Hcl	152	39
Glimepiride	Glimepiride	135	38
Metoprolol Succinate	Metoprolol Succinate	131	32
Simvastatin	Simvastatin	130	33
Hydrochlorothiazide	Hydrochlorothiazide	129	33
Rosuvastatin Calcium	Rosuvastatin Calcium	127	34
Pravastatin Sodium	Pravastatin Sodium	120	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	108	28
Metoprolol Tartrate	Metoprolol Tartrate	99	28
Tizanidine Hcl	Tizanidine Hcl	84	22
Prednisone	Prednisone	75	47
Albuterol Sulfate Hfa	Albuterol Sulfate	74	25
Montelukast Sodium	Montelukast Sodium	74	19
Citalopram Hbr	Citalopram Hydrobromide	71	17
Lorazepam	Lorazepam	69	20
Meloxicam	Meloxicam	66	27
Tamsulosin Hcl	Tamsulosin Hcl	66	23
Allopurinol	Allopurinol	61	18
Celecoxib	Celecoxib	61	19
Escitalopram Oxalate	Escitalopram Oxalate	60	17
Jardiance	Empagliflozin	59	21
Potassium Chloride	Potassium Chloride	59	13
Furosemide	Furosemide	58	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	13
Alprazolam	Alprazolam	55	suppressed
Tradjenta	Linagliptin	54	15
Mounjaro	Tirzepatide	53	12
Paroxetine Hcl	Paroxetine Hcl	50	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	48	11
Famotidine	Famotidine	47	14
Trazodone Hcl	Trazodone Hcl	47	13
Eliquis	Apixaban	45	11
Fluticasone Propionate	Fluticasone Propionate	44	18
Tramadol Hcl	Tramadol Hcl	44	13
Atenolol	Atenolol	43	suppressed
Januvia	Sitagliptin Phosphate	43	17
Farxiga	Dapagliflozin Propanediol	42	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	suppressed
Ibuprofen	Ibuprofen	39	13
Synthroid	Levothyroxine Sodium	39	12
Methocarbamol	Methocarbamol	37	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Carbamazepine	Carbamazepine	33	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Valsartan	Valsartan	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Testosterone Cypionate	Testosterone Cypionate	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Glipizide	Glipizide	27	suppressed
Benztropine Mesylate	Benztropine Mesylate	26	suppressed
Carvedilol	Carvedilol	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Azithromycin	Azithromycin	23	22
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Methylprednisolone	Methylprednisolone	22	17
Ondansetron Odt	Ondansetron	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Bumetanide	Bumetanide	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	18
Ezetimibe	Ezetimibe	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Topiramate	Topiramate	19	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Glipizide Er	Glipizide	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Vraylar	Cariprazine Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error